Simian Varicella Virus: Molecular Virology and Mechanisms of Pathogenesis

2021 ◽  
Author(s):  
Allen Jankeel ◽  
Izabela Coimbra-Ibraim ◽  
Ilhem Messaoudi

2021 ◽  
Vol 37 (1) ◽  
Author(s):  
Jong-Min Kim ◽  
Chung-Gyu Park

Abstract Background The objective of this study was to investigate whether the use of live attenuated varicella zoster virus (VZV) MAV vaccination can efficiently induce VZV antibody production in naive rhesus monkeys as an approach to prevent simian varicella virus (SVV) reactivation in animals immunosuppressed for transplantation studies. Results Clinically available human VZV vaccine was used to induce the production of anti-VZV antibodies in rhesus monkeys. A vial of the vaccine was subcutaneously injected at 0 week, and the second and third vaccination was performed at 5 and 6 weeks by intratracheal inoculation. The titer of anti-VZV IgG was assessed at 0, 2, 4, 6, and 7 weeks. At 2 weeks, 3/16 were seropositive for VZV IgG. At 6 weeks, 9/16 were shown to be seropositive. At 7 weeks, 16/16 were found to be seropositive. Conclusions The VZV vaccine via intratrachael inoculation was shown to induce VZV IgG humoral immunity in rhesus monkeys and may be important immunosuppressed macaques for transplantation studies. Although the humoral immunity produced is an important finding, further studies will be necessary to confirm possible protection and it could protect probably against SVV infection in rhesus monkey.



2014 ◽  
Vol 20 (5) ◽  
pp. 526-530 ◽  
Author(s):  
Vicki Traina-Dorge ◽  
Robert Sanford ◽  
Stephanie James ◽  
Lara A. Doyle-Meyers ◽  
Eileen de Haro ◽  
...  


1994 ◽  
Vol 23 (3-4) ◽  
pp. 219-224 ◽  
Author(s):  
K.F. Soike ◽  
J.-L. Huang ◽  
J.W. Russell ◽  
V.J. Whiterock ◽  
J.E. Sundeen ◽  
...  




Author(s):  
Ravi Mahalingam ◽  
Ilhem Messaoudi ◽  
Don Gilden


1992 ◽  
Vol 26 (3) ◽  
pp. 255-266 ◽  
Author(s):  
Carla Y. Pumphrey ◽  
Wayne L. Gray




Sign in / Sign up

Export Citation Format

Share Document